AMPHASTAR PHARMACEUTICALS IN - NOTE 2.000% 3/1

Historical Institutional Holders from Q3 2024 to Q4 2024

All holders as of December 31, 2024
Q4 2024
Type / Class
Debt / NOTE 2.000% 3/1
Principal, excl. options Q4 2024
310M
Holdings value Q4 2024
$291M
Value change Q4 2024
-$11.3M
Grand Portfolio weight change Q4 2024
0%
Number of holders
36
Number of buys Q4 2024
17
Number of sells Q4 2024
-21
Average buys Q4 2024 %
+0.001%
Average sells Q4 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q4 $310M $291M -$11.3M $0.93 36
2024 Q3 $320M $339M +$336M $1.06 35